(Q35716594)

9 August 2017

1 reference

title

The implementation of acute versus chronic animal models for treatment discovery in Parkinson's disease (English)

1 reference

9 August 2017

1 reference

Gregory L Willis

1

1 reference

9 August 2017

Gerard A Kennedy

series ordinal

2

1 reference

9 August 2017

publication date

1 January 2004

1 reference

Reviews in the Neurosciences

9 August 2017

published in

1 reference

9 August 2017

volume

15

1 reference

9 August 2017

issue

1

1 reference

9 August 2017

page(s)

75-87

1 reference

Protective effect of melatonin in a chronic experimental model of Parkinson's disease

9 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2004.15.1.75

Methods for the early diagnosis of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2004.15.1.75

A chronic MPTP model reproducing the slow evolution of Parkinson's disease: evolution of motor symptoms in the monkey

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2004.15.1.75

Neural grafting in animal models of neurodegenerative diseases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2004.15.1.75

The interrelationship of forebrain and midbrain structures involved in feeding behavior.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2004.15.1.75

The neocortex and visual placing in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2004.15.1.75

Biochemical and behavioral recovery in a rodent model of Parkinson's disease following stereotactic implantation of dopamine-containing liposomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2004.15.1.75

A pilot trial of high-dose alpha-tocopherol and ascorbate in early Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2004.15.1.75

Animal models of Parkinson's disease: an empirical comparison with the phenomenology of the disease in man.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2004.15.1.75

21 January 2018

Toxicology of Melatonin

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2004.15.1.75

The contribution of the MPTP-treated primate model to the development of new treatment strategies for Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2004.15.1.75

Melatonin protects nigral dopaminergic neurons from 1-methyl-4-phenylpyridinium (MPP+) neurotoxicity in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2004.15.1.75

Neuroimaging of animal models of brain disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2004.15.1.75

Oxidative stress induced by phenylketonuria in the rat: Prevention by melatonin, vitamin E, and vitamin C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2004.15.1.75

Melatonin receptors and signal transduction mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2004.15.1.75

Circling behavior in rats with partial, unilateral nigro-striatal lesions: Effect of amphetamine, apomorphine, and DOPA

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2004.15.1.75

10.1515/REVNEURO.2004.15.1.75

21 January 2018

Identifiers

DOI

1 reference

9 August 2017

1 reference